Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.

Nucleic acids research - 4 Jan 2016

Gohlke Bjoern-Oliver, Nickel Janette, Otto Raik, Dunkel Mathias, Preissner Robert

Abstract excerpt

Here, we present an updated version of CancerResource, freely available without registration at http://bioinformatics.charite.de/care. With upcoming information on target expression and mutations in patients' tumors, the need for systems supporting decisions on individual therapy is growing. This knowledge is based on numerous, experimentally validated drug-target interactions and supporting analyses such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to Databases, Genetic

Share to Gene Expression

Share to Mutation

Share to Neoplasm Proteins

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26590406
DOI: 10.1093/nar/gkv1283
PMCID: PMC4702908

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.PMID 26590406Read ↗

MUSTARD-a comprehensive resource of mutation-specific therapies in cancer.Semantic proximity Read ↗

Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell linesSemantic proximity Read ↗

Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.Semantic proximity Read ↗

Predicting Tumor Response to Drugs based on Gene-Expression Biomarkers of Sensitivity Learned from Cancer Cell LinesSemantic proximity Read ↗

Cancer driver drug interaction explorer.Semantic proximity Read ↗

CancerDR: cancer drug resistance database.Semantic proximity Read ↗

Methods and resources to access mutation-dependent effects on cancer drug treatment.Semantic proximity Read ↗

Predicting Tumor Response to Drugs Based on Gene-expression Biomarkers of Sensitivity Learned From Cancer Cell LinesSemantic proximity Read ↗

Integrative Statistical Inferences for Drug Sensitivity Biomarkers in CancerSemantic proximity Read ↗

Dr.Paso: Drug response prediction and analysis system for oncology researchSemantic proximity Read ↗

Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.Semantic proximity Read ↗

canSAR: updated cancer research and drug discovery knowledgebase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.